Literature DB >> 11037977

Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types.

A V Andjelkovic1, D Kerkovich, J S Pachter.   

Abstract

As astrocytes are a source of monocyte chemoattractant protein-1 (MCP-1) and lie in close apposition to brain microvessels, interactions between astrocytes and infiltrating monocytes might regulate production of this chemokine. To investigate this possibility, a monocyte:astrocyte co-culture model was utilized to assess the respective roles of these two cell types in regulating MCP-1 production. Results indicate that, while neither monocytes nor astrocytes alone produce detectable levels of MCP-1, co-culture of these two cell types results in time-dependent production of this chemokine. Such production requires de novo protein synthesis and is dependent on physical contact between monocytes and astrocytes, involving engagement of the cell-adhesion molecules ICAM-1 and VCAM-1. Additionally, interleukin 1-beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) are soluble mediators of this response. These findings imply that monocyte extravasation into the CNS may be critically regulated at the blood-brain barrier by specialized monocyte:astrocyte interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037977

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Qualitative and quantitative analysis of monocyte transendothelial migration by confocal microscopy and three-dimensional image reconstruction.

Authors:  A V Andjelkovic; M R Zochowski; F Morgan; J S Pachter
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

2.  Imiquimod and interferon-alpha augment monocyte-mediated astrocyte secretion of MCP-1, IL-6 and IP-10 in a human co-culture system.

Authors:  Michael D Rizzo; Robert B Crawford; Anthony Bach; Sera Sermet; Andrea Amalfitano; Norbert E Kaminski
Journal:  J Neuroimmunol       Date:  2019-05-20       Impact factor: 3.478

Review 3.  Immune cell regulation of glia during CNS injury and disease.

Authors:  Andrew D Greenhalgh; Sam David; F Chris Bennett
Journal:  Nat Rev Neurosci       Date:  2020-02-10       Impact factor: 34.870

4.  Distribution of ICAM-1 immunoreactivity during aging in the human orbitofrontal cortex.

Authors:  Jose Javier Miguel-Hidalgo; Sorcha Nithuairisg; Craig Stockmeier; Grazyna Rajkowska
Journal:  Brain Behav Immun       Date:  2006-07-07       Impact factor: 7.217

Review 5.  Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.

Authors:  Michael D Rizzo; Joseph E Henriquez; Lance K Blevins; Anthony Bach; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2020-05-14       Impact factor: 4.147

6.  Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system.

Authors:  Zhi W Wang; Luciana Sarmento; Yuhuan Wang; Xia-qing Li; Vikas Dhingra; Tesfai Tseggai; Baoming Jiang; Zhen F Fu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 7.  Progress towards biocompatible intracortical microelectrodes for neural interfacing applications.

Authors:  Mehdi Jorfi; John L Skousen; Christoph Weder; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2014-12-02       Impact factor: 5.379

8.  Leukocyte recruitment and ischemic brain injury.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neuromolecular Med       Date:  2009-07-05       Impact factor: 3.843

9.  Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia.

Authors:  Pavle Repovic; Etty N Benveniste
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  Δ9-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7-Stimulated Human Coculture.

Authors:  Michael D Rizzo; Robert B Crawford; Anthony Bach; Sera Sermet; Andrea Amalfitano; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2019-08-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.